Terms: = Kidney tumors AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Treatment
8590 results:
1. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
2. Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Kurmasheva N; Said A; Wong B; Kinderman P; Han X; Rahimic AHF; Kress A; Carter-Timofte ME; Holm E; van der Horst D; Kollmann CF; Liu Z; Wang C; Hoang HD; Kovalenko E; Chrysopoulou M; Twayana KS; Ottosen RN; Svenningsen EB; Begnini F; Kiib AE; Kromm FEH; Weiss HJ; Di Carlo D; Muscolini M; Higgins M; van der Heijden M; Bardoul A; Tong T; Ozsvar A; Hou WH; Schack VR; Holm CK; Zheng Y; Ruzek M; Kalucka J; de la Vega L; Elgaher WAM; Korshoej AR; Lin R; Hiscott J; Poulsen TB; O'Neill LA; Roy DG; Rinschen MM; van Montfoort N; Diallo JS; Farin HF; Alain T; Olagnier D
Nat Commun; 2024 May; 15(1):4096. PubMed ID: 38750019
[TBL] [Abstract] [Full Text] [Related]
3. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
[TBL] [Abstract] [Full Text] [Related]
4. Single-layer versus double-layer renorrhaphy technique during robot-assisted partial nephrectomy: impact on perioperative outcomes, complications, and functional outcomes.
Bertolo R; Ditonno F; Veccia A; DE Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A
Minerva Urol Nephrol; 2024 Apr; 76(2):176-184. PubMed ID: 38742552
[TBL] [Abstract] [Full Text] [Related]
5. Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma.
Sammarco E; Rossetti M; Salfi A; Bonato A; Viacava P; Masi G; Galli L; Faviana P
Med Oncol; 2024 May; 41(6):150. PubMed ID: 38740647
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of dmft and behavior rating scores between children with systemic disease and healthy children at the first dental visit.
Erbas Unverdi G; Ozgur B; Gungor HC; Casamassimo PS
BMC Oral Health; 2024 May; 24(1):548. PubMed ID: 38730438
[TBL] [Abstract] [Full Text] [Related]
7. Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.
Turjap M; Pelcová M; Gregorová J; Šmak P; Martin H; Štingl J; Peš O; Juřica J
Ther Drug Monit; 2024 Jun; 46(3):321-331. PubMed ID: 38723115
[TBL] [Abstract] [Full Text] [Related]
8. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
Wei G; Zhao Y; Feng S; Yuan J; Xu G; Lv T; Yang J; Kong L; Yang J
BMC Cancer; 2024 May; 24(1):558. PubMed ID: 38702621
[TBL] [Abstract] [Full Text] [Related]
9. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
10. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
[TBL] [Abstract] [Full Text] [Related]
11. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
[TBL] [Abstract] [Full Text] [Related]
12. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
[TBL] [Abstract] [Full Text] [Related]
13. Squamous Cell Carcinoma Arising From Epidermal Cyst: A Case Series of 9 Patients With a Literature Review.
Kim JY; Min S; Park JK; Kim SW
Ann Plast Surg; 2024 May; 92(5):575-579. PubMed ID: 38669586
[TBL] [Abstract] [Full Text] [Related]
14. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
15. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
[TBL] [Abstract] [Full Text] [Related]
17. Open versus minimally invasive nephroureterectomy in octogenarians: An analysis of surgical approach trends, outcomes, and survival analysis with propensity matching.
Trecarten S; Bhandari M; Abdelaziz A; Noel O; Liss M; Dursun F; Svatek R; Mansour AM
Urol Oncol; 2024 Jul; 42(7):220.e9-220.e19. PubMed ID: 38631967
[TBL] [Abstract] [Full Text] [Related]
18. NTRK-rearranged spindle cell neoplasm: Initial observation of imaging appearance and clinicopathologic correlation.
Spano M; Davis-Hayes C; Hameed M; Benayed R; Hwang S
Clin Imaging; 2024 Jun; 110():110134. PubMed ID: 38631176
[TBL] [Abstract] [Full Text] [Related]
19. Ablation of kidney tumors in Patients with Substantial kidney Impairment: Current Status.
Iguchi T; Matsui Y; Tomita K; Uka M; Umakoshi N; Kawabata T; Gobara H; Araki M; Hiraki T
Curr Oncol Rep; 2024 May; 26(5):573-582. PubMed ID: 38625653
[TBL] [Abstract] [Full Text] [Related]
20. Timing, incidence and management of delayed bleeding after partial nephrectomy in patients at risk for recurrent, bilateral, multifocal renal tumors.
Gomella PT; Solomon J; Ahdoot M; Gurram S; Lebastchi AH; Levy E; Krishnasamy V; Kassin MT; Chang R; Wood BJ; Linehan WM; Ball MW
Urol Oncol; 2024 Jul; 42(7):222.e1-222.e7. PubMed ID: 38614921
[TBL] [Abstract] [Full Text] [Related]
[Next]